<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01796353</url>
  </required_header>
  <id_info>
    <org_study_id>CopenHeart-SF</org_study_id>
    <nct_id>NCT01796353</nct_id>
  </id_info>
  <brief_title>Effects of a Comprehensive Sexual Rehabilitation Programme in Heart Patients</brief_title>
  <acronym>CopenHeartSF</acronym>
  <official_title>A Randomized Clinical Trial of a Comprehensive Sexual Rehabilitation Programme Versus Usual Care in Male Patients With Impaired Sexual Function and Ischemic Heart Disease or Implantable Cardioverter Defibrillator</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rigshospitalet, Denmark</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Bispebjerg Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Rigshospitalet, Denmark</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective is to investigate the effect of a comprehensive sexual rehabilitation program,&#xD;
      consisting of a psycho-educative component and a physical exercise component.&#xD;
&#xD;
      The primary hypothesis is that, a comprehensive sexual rehabilitation program improves sexual&#xD;
      function.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Sexual function is an important aspect of quality of life. There is a link between heart&#xD;
      disease and sexual dysfunction. Heart disease lowers the activity or the ability to perform&#xD;
      the sexual activity. Sexual problems have a negative impact on quality of life and&#xD;
      well-being, and sexual dysfunction is associated with anxiety and depression. The causes of&#xD;
      sexual dysfunction are physical changes (the disease), mental changes and adverse reactions&#xD;
      from medication. Despite the fact, that several international guidelines recommend that&#xD;
      health professionals address sexual function in patients with heart disease, this is rarely&#xD;
      done in practice. In Denmark there is no consensus or practice on how or where patients with&#xD;
      heart disease and sexual dysfunction should be treated. Some patients are treated with&#xD;
      phosphodiesterase type 5 inhibitors and a few referred to sexological clinics.&#xD;
      Non-pharmacological rehabilitation interventions such as physical exercise, pelvic floor&#xD;
      exercise, and sexual therapy have shown potential beneficial effect on sexual function.&#xD;
      However, the effects have not been tested sufficiently, have not been tested in combination,&#xD;
      and have never been tested in a Danish population.&#xD;
&#xD;
      Objective: The objective of this trial is to investigate the effect of a comprehensive sexual&#xD;
      rehabilitation intervention program, consisting of a psycho-educative component and an&#xD;
      exercise-training component plus treatment as usual versus treatment as usual in male&#xD;
      patients with impaired sexual function and implantable cardioverter defibrillator or ischemic&#xD;
      heart disease.&#xD;
&#xD;
      Design: CopenHeartSF is an investigator-initiated randomised clinical trial with blinded&#xD;
      outcome assessment, including two university hospitals, with 1:1 central randomisation to&#xD;
      sexual rehabilitation plus usual care versus usual care alone.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2013</start_date>
  <completion_date type="Actual">January 2017</completion_date>
  <primary_completion_date type="Actual">November 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>International Index of Erectile Function (IIEF)</measure>
    <time_frame>16 week</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Psychosocial adjustment to illness scale (PAIS-SR)sexual relationship domain</measure>
    <time_frame>16 week</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">154</enrollment>
  <condition>Ischaemic Heart Disease</condition>
  <condition>Cardiac Arrhythmia</condition>
  <condition>Sexual Dysfunction</condition>
  <arm_group>
    <arm_group_label>sexual rehabilitation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>exercise plus psycho-education</description>
  </arm_group>
  <arm_group>
    <arm_group_label>usual care</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>usual care</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>sexual rehabilitation</intervention_name>
    <description>exercise plus psycho-education</description>
    <arm_group_label>sexual rehabilitation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Usual care</intervention_name>
    <description>usual care</description>
    <arm_group_label>usual care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male patients above 18 years with sexual dysfunction associated with implantable&#xD;
             cardioverter defibrillator or with ischemic heart disease verified by coronary&#xD;
             angiography, which have a partner, speaks and understands Danish and provides a&#xD;
             written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients at intermediate or high risk according to their cardiovascular status&#xD;
             according to guidelines, with diseases in the urinary tract, who exercise intense more&#xD;
             than 3 hours a week, patients with neurological or orthopedic deficits which prevent&#xD;
             training, patients with cognitive deficits which prevents interviews, and patients who&#xD;
             are included in ongoing research prohibiting additional research participation are&#xD;
             excluded.&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Selina Berg, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Heart Centre, Rigshospitalet, Copenhagen, Denmark</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hjertecentret, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9</name>
      <address>
        <city>Copenhagen</city>
        <state>OE</state>
        <zip>2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <study_first_submitted>February 19, 2013</study_first_submitted>
  <study_first_submitted_qc>February 20, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 21, 2013</study_first_posted>
  <last_update_submitted>May 12, 2017</last_update_submitted>
  <last_update_submitted_qc>May 12, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 15, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rigshospitalet, Denmark</investigator_affiliation>
    <investigator_full_name>Selina Kikkenborg Berg</investigator_full_name>
    <investigator_title>Researcher, Ph.D, post.doc.</investigator_title>
  </responsible_party>
  <keyword>heart disease</keyword>
  <keyword>sexual dysfunction</keyword>
  <keyword>exercise test</keyword>
  <keyword>comprehensive rehabilitation</keyword>
  <keyword>complex intervention</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Arrhythmias, Cardiac</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

